Soliris®
Soliris® (eculizumab) is a monoclonal antibody that binds to proteins in the blood that can destroy red blood cells. Specifically it is a complement inhibitor antibody used to treat myasthenia gravis and certain hemolytic (blood-related) syndromes.
For more information, visit the patient website for this drug. Speak with your healthcare provider to learn if this drug is right for you.
WHAT IT TREATS: |
MANUFACTURER: Alexion Pharmaceuticals |
CLASS: Biologics (complement inhibitors) |
PRESCRIBED BY: Neurologists |
HOW ADMINISTERED: IV infusion |
FREQUENCY: Every other week |
Length of infusion: 45 mins |
FOR MORE INFORMATION: |